Return to search

Growth Hormone Splicing and Treatment of Disease Using RNA Interference

Splicing is the regulated removal of introns and the concurrent ligation of exons to produce mature mRNA transcripts. Variability in this tightly regulated process is responsible for an extraordinarily diverse proteome from a relatively small mammalian genome. Alternative splicing can lead to differential exon inclusion or exclusion, as can aberrant splicing, and such transcripts therefore differ from constitutively spliced transcripts. Where mistakes in splicing cause disease, the resulting mutant transcripts appear to be ideal targets for RNA interference (RNAi). In the case of inappropriate exon inclusion, small interfering RNAs (siRNAs) can be targeted to specific exons. When exon skipping prevails, siRNAs can be designed complementary to the specific exon-exon junctions that are not present in normal transcripts. The human growth hormone gene, GH-1, nicely illustrates these points. Constitutive splicing of all 5 exons produces the normal hormone but aberrant skipping of exon 3 can lead to the production of a dominant negative isoform and associated Isolated Growth Hormone Deficiency type II (IGHD II). This thesis describes research into understanding the causes of exon 3 skipping and shows that siRNAs targeting the unique exon 2-exon 4 sequence in mutant transcripts can prevent onset of IGHD II in a mouse model.

Identiferoai:union.ndltd.org:VANDERBILT/oai:VANDERBILTETD:etd-02272008-094210
Date28 February 2008
CreatorsShariat, Nikki
ContributorsJohn A. Phillips III, Ronald B. Emeson, Katherine L. Friedman, James G. Patton, Todd R. Graham
PublisherVANDERBILT
Source SetsVanderbilt University Theses
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.library.vanderbilt.edu/available/etd-02272008-094210/
Rightsunrestricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to Vanderbilt University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Page generated in 0.1972 seconds